Share on LinkedInShare on LinkedIn

ARTICLE · 06 OCTOBER 2014

Managing Anaphylaxis

It’s hard to avoid the tragic headline news stories of young children who have died from anaphylactic and allergic reactions.

CanadaFood, Drugs, Healthcare, Life Sciences
Nora Constas
Nora Constas

It's hard to avoid the tragic headline news stories of young children who have died from anaphylactic and allergic reactions. Recently, a 12-year-old girl in Ontario died of an anaphylactic reaction after eating ice cream at the local mall. Sadly, her story is not unique to Ontario or Canada — with similar tragedies happening regularly around the world.

Anaphylactic reactions are often the result of underlying causes or new exposures that may not have triggered a reaction in the past. In an effort to reduce the number of deaths from anaphylaxis, organizations, public venues, and recreational facilities should conduct a risk-benefit analysis of housing Epi-Pen® and/or Twin-Ject® epinephrine on site to help manage the symptoms of anaphylaxis.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from